Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 26Pain, Postoperative 17Neoplasms 13Lung Neoplasms 12Brain Neoplasms 12Depression 7Carcinoma, Hepatocellular 7Pain 6Colonic Neoplasms 6Thyroid Neoplasms 5Stomach Neoplasms 5Prostatic Neoplasms 5Leiomyoma 5Head and Neck Neoplasms 5Agnosia 5Ovarian Neoplasms 4Multiple Myeloma 4Delirium 4Colorectal Neoplasms 4Anxiety Disorders 4Supratentorial Neoplasms 3Rectal Neoplasms 3Pancreatic Neoplasms 3Myofibroma 3Lymphoma 3Hemorrhage 3Fatigue 3Emergence Delirium 3Chronic Pain 3Carcinoma, Non-Small-Cell Lung 3

Interventions

pembrolizumab 2fludarabine 2Radiosurgery 2Paclitaxel 2Gemcitabine 2Cyclophosphamide 2Cisplatin 2Carboplatin 2Anthropogenic Effects 2venetoclax 1umbralisib 1ublituximab 1regorafenib 1pazopanib 1niraparib 1neratinib 1lutetium Lu 177 dotatate 1ibrutinib 1grapiprant 1fludarabine phosphate 1famitinib 1encorafenib 1copanlisib 1cemiplimab 1capivasertib 1camrelizumab 1brigatinib 1binimetinib 1axicabtagene ciloleucel 1avelumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Disease Progression × Saline Solution × Clear all
NCT05560035 2022-09-29

The Effect of Intravenous Lidocaine on THBS2 and Angiogenic Factors Expression in Women Undergoing Cervical Cancer Surgery

General Hospital of Ningxia Medical University

Phase NA Unknown
60 enrolled
Gynecologic

Uterine Cervical Neoplasms, Neoplasm Metastasis, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡